<table className="table"><caption><p>Clinical Presentation, Evaluation, and Management of Vaginitis</p></caption><thead><tr><th colSpan="1" rowSpan="1"><p>Cause of Vaginitis</p></th><th colSpan="1" rowSpan="1"><p>Clinical Presentation</p></th><th colSpan="1" rowSpan="1"><p>Evaluation</p></th><th colSpan="1" rowSpan="1"><p>Management</p></th></tr></thead><tbody><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Symptomatic bacterial vaginosis (pregnant or not pregnant)</p></td><td colSpan="1" rowSpan="1"><p>Malodorous or “fishy” vaginal discharge</p><p>Increased thin white or gray discharge</p><p>Symptoms other than malodor may be minimal</p></td><td colSpan="1" rowSpan="1"><p>Diagnosis requires three of four findings (Amsel criteria):</p><p>1. pH &gt;4.5</p><p>2. Thin homogenous discharge</p><p>3. KOH amine whiff test result positive</p><p>4. Saline wet mount with &gt;20% epithelial clue cells (see <span className="text-nowrap">Figure: Clue Cells on Wet Mount)</span></p><p>Positive NAAT result</p></td><td colSpan="1" rowSpan="1"><p>Metronidazole: 500 mg orally twice daily for 7 d<sup>a</sup> or vaginal gel (0.75%) 5 g intravaginally at bedtime for 5 nights</p><p>Clindamycin: Vaginal cream (2%) 5 g intravaginally for 7 nights</p><p>Sexual partners do not require treatment</p><p>Avoid sexual activity (or use condoms) during treatment</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Vulvovaginal candidiasis</p></td><td colSpan="1" rowSpan="1"><p>Itching, irritation, dysuria, dyspareunia, vulvodynia, excoriation, erythema, fissures</p><p>Increased thick white discharge</p></td><td colSpan="1" rowSpan="1"><p>pH ≤4.5</p><p>Negative KOH amine whiff test result</p><p>KOH wet mount shows hyphae, pseudohyphae, or yeast (see <span className="text-nowrap">Figure: Vulvovaginal Candidiasis Findings on Wet Mount)</span></p><p>Positive NAAT result</p></td><td colSpan="1" rowSpan="1"><p>Sexual partners do not require treatment</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Uncomplicated<sup>b</sup></p></td><td colSpan="1" rowSpan="1"><p></p></td><td colSpan="1" rowSpan="1"><p></p></td><td colSpan="1" rowSpan="1"><p>Over-the-counter intravaginal agents:</p><p>Clotrimazole: 1% cream 5 g intravaginally daily for 7-14 d; or 2% cream 5 g intravaginally daily for 3 d</p><p>Miconazole: 2% cream 5 g intravaginally daily for 7 d; or 4% cream 5 g intravaginally daily for 3 d; or 100-mg vaginal suppository, one suppository daily for 7 d; or 200-mg vaginal suppository, one suppository for 3 d; or 1200-mg vaginal suppository, one suppository for 1 d</p><p>Tioconazole: 6.5% ointment 5 g intravaginally in a single application</p><p>Prescription intravaginal agents:</p><p>Butoconazole: 2% cream (single-dose bioadhesive product) 5 g intravaginally in a single application</p><p>Terconazole: 0.4% cream 5 g intravaginally daily for 7 d; or 0.8% cream 5 g intravaginally daily for 3 d; or 80-mg vaginal suppository, one suppository daily for 3 d</p><p>Prescription oral agent:</p><p>Fluconazole: 150 mg orally as a single dose</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Complicated<sup>c</sup></p></td><td colSpan="1" rowSpan="1"><p></p></td><td colSpan="1" rowSpan="1"><p></p></td><td colSpan="1" rowSpan="1"><p>Longer duration of initial oral or topical treatment, followed by maintenance therapy as needed:</p><p>Recurrent:</p><p>Fluconazole: 150 mg orally every 3 d for a total of three doses; or topical imidazole therapy for 7-14 nights</p><p>Maintenance therapy for refractory or recurrent symptoms: Fluconazole, 150 mg orally weekly for 6 mo</p><p>Severe:</p><p>Topical azole for 7-14 d or fluconazole, 150 mg for two doses separated by 72 h</p><p>Nonalbicans species:</p><p>Nonfluconazole topical azole for 7-14 d</p><p>Pregnancy:</p><p>Topical azole for 7 d; do not use fluconazole</p></td></tr><tr className="group_1-3 row-odd"><td colSpan="1" rowSpan="1"><p>Trichomoniasis</p></td><td colSpan="1" rowSpan="1"><p>Increased discolored discharge (yellowish, green, gray, and/or frothy)</p><p>Dyspareunia, dysuria, itch, erythema, postcoital bleeding</p><p>Punctate cervical hemorrhages (“strawberry” cervix)</p></td><td colSpan="1" rowSpan="1"><p>Negative KOH amine whiff test result</p><p>Saline wet mount with trichomonads, leukocytes (see <span className="text-nowrap">Figure: Trichomonads on Wet Mount)</span></p><p>Positive NAAT or rapid assay result</p></td><td colSpan="1" rowSpan="1"><p>For women: oral metronidazole, 500 mg twice daily for 7 d, or oral tinidazole, 2 g as a single dose.</p><p>For men: oral metronidazole, 2 g as a single dose, or oral tinidazole, 2 g as a single dose</p><p>Treatment of sexual partners is recommended to prevent reinfection</p></td></tr></tbody></table>